R.E.B.E.L.EM - January 03, 2019 - By Rick Pescatore
"Conclusion
No current rigorous trial has yet examined procalcitonin’s performance in this narrow and nuanced framework, but the collated and considered information available to use suggests that adding this simple test may provide a much-needed diagnostic beacon and potentially lead to better care in real-world applications."
